• No results found

MCI and AD

Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD)

Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD)

... in MCI for diagnostic purposes, only the identification and localization of regions whose metabolism is able to predict the speed of progression in patients with mild cognitive impairment due to Alzheimer ’ s ...

13

Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey

Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey

... that MCI was considered a useful ...in MCI based on AD biomarkers (prodromal AD/MCI due to ...of MCI and prodromal AD/MCI due to AD ...prodromal ...

12

Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data

Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data

... of MCI-to-AD conversion, including Mini Mental State Examination (MMSE), Clinical Dementia Rating Sum of Boxes (CDR-SB), Alzheimer’s Disease Assessment Scale-cognitive subscale (ADAS-cog), Logical Memory ...

12

Re-evaluation of soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for early diagnosis of dementia disorders

Re-evaluation of soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for early diagnosis of dementia disorders

... in AD and MCI-AD patients could result from increased BACE1 processing of APP, considering that BACE1 pro- tein levels or activities are increased in brains of AD as well as MCI ...

9

Souvenaid in the management of mild cognitive impairment: an expert consensus opinion

Souvenaid in the management of mild cognitive impairment: an expert consensus opinion

... with MCI or AD [4, ...in MCI and AD is constantly evolving and has been reviewed extensively in recent papers ...of MCI [71], for example, to enhance the supply of precursors re- quired ...

11

Minimally invasive biomarker confirms glial activation present in Alzheimer's disease: a preliminary study

Minimally invasive biomarker confirms glial activation present in Alzheimer's disease: a preliminary study

... neuroinflammation is the immediate cause of MCI and AD or merely a secondary effect of neuronal injury. A conclusion in favor of the former mechanism would support the renewed impetus for preventative ...

5

Study protocol: Language profile in mild cognitive impairment: A prospective study

Study protocol: Language profile in mild cognitive impairment: A prospective study

... of MCI and AD (15-17). The early language damage of MCI is created from failure at the pragmatic and seman- tic level of language process ...with MCI to reveal the difficulty in verbal ...

5

The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease

The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease

... with MCI and AD dementia were diagnosed using available clinical and cognitive information in accordance with the updated 2011 National Institute on Aging– Alzheimer’s Association workgroup diagnostic ...

8

Calmodulin levels in blood cells as a potential biomarker of Alzheimer’s disease

Calmodulin levels in blood cells as a potential biomarker of Alzheimer’s disease

... blood mononuclear cells from control, mild cognitive impairment and Alzheimer ’ s disease patients. Peripheral blood mononuclear cells were isolated from freshly obtained blood from 15 control individuals, seven mild ...

10

Identification of peripheral inflammatory markers between normal control and Alzheimer's disease

Identification of peripheral inflammatory markers between normal control and Alzheimer's disease

... in MCI or AD group compared with NC group, ...in MCI and AD patients (respectively, p < ...to AD patients ( p = ...the MCI patients, but the difference was not significant ...

6

Plasma protein profiling of Mild Cognitive Impairment and Alzheimer’s disease using iTRAQ quantitative proteomics

Plasma protein profiling of Mild Cognitive Impairment and Alzheimer’s disease using iTRAQ quantitative proteomics

... of MCI and ...of MCI and ...of MCI and ...in MCI and ...of MCI and AD and that iTRAQ pro- teomics is an excellent screening and discovery ...of MCI or AD, and may ...

13

An overview of quantitative magnetic resonance imaging analysis studies in the assessment of alzheimer’s disease

An overview of quantitative magnetic resonance imaging analysis studies in the assessment of alzheimer’s disease

... (NC), MCI and AD ...classified MCI from AD patients with high ...for AD vs controls, and for MCI vs controls an accuracy of 83%, sensitivity 83% and specificity ...both AD ...

7

MILD COGNITIVE IMPAIRMENT: WHATS NEW ABOUT?

MILD COGNITIVE IMPAIRMENT: WHATS NEW ABOUT?

... Subsequently, MCI has been recognized as a pathological condition, and many researchers have focused their attention to the identification of its diagnostic criteria; different subtypes of MCI, with ...

8

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease

... of MCI, a condition that is often but not always pro- dromic to the development of ...in MCI a partial, initial up regula- tion of inflammasome proteins limited to NLRP proteins is ...of MCI ...

14

MMSE Subscale Scores as Useful Predictors of AD Conversion in Mild Cognitive Impairment

<p>MMSE Subscale Scores as Useful Predictors of AD Conversion in Mild Cognitive Impairment</p>

... were MCI at baseline evaluation and had at least one 2-year follow-up ...with MCI met the current consensus criteria for amnestic MCI: 30 a memory complaint by the subject or their repre- sentative, ...

9

Alzheimer's Disease: What Is Known About Delaying Or  Preventing Its Onset Or Progression?

Alzheimer's Disease: What Is Known About Delaying Or Preventing Its Onset Or Progression?

... of MCI to ...of MCI patients stay stable or return to ordinary without ...have MCI is summed-up by the accompanying quote: "Treatment (for MCI) ought not be recommended in light of current ...

7

Detection of Alzheimer\\\\\\\\\\\\\\\'s Disease using Multitracer Positron Emission Tomography Imaging

Detection of Alzheimer\\\\\\\\\\\\\\\'s Disease using Multitracer Positron Emission Tomography Imaging

... Data used in this research were obtained from the Alzheimer's disease Neuroimaging Initiative (ADNI) database (http://www.loni.ucla.edu/ADNI). In this study, 57 subjects, including 18 AD patients, 20 MCI ...

6

PubMedCentral-PMC5372170.pdf

PubMedCentral-PMC5372170.pdf

... Effects of Hierarchical Structure. To examine the effectiveness of the proposed hierarchical framework, Fig. 1 compares the classification accuracy (ACC) and area under the receiver operating characteristic (ROC) curve ...

11

Chinese version of Montreal Cognitive Assessment Basic for discrimination among different severities of Alzheimer&rsquo;s disease

Chinese version of Montreal Cognitive Assessment Basic for discrimination among different severities of Alzheimer&rsquo;s disease

... verify MoCA-BC as a capable test to help discriminate the severity of AD instead of MMSE. Our research concluded that MoCA-BC was a highly reliable and sensitive tool to not only screen for MCI, but also ...

8

Relationship between oxysterols and mild cognitive impairment in the elderly: a case–control study

Relationship between oxysterols and mild cognitive impairment in the elderly: a case–control study

... Despite that, studies analyzing the associations be- tween plasma 27–OHC level and cognitive decline yielded conflicting results. Timothy M. Hughes et al. [27] recently found that the increase of plasma 27–OHC levels was ...

6

Show all 10000 documents...

Related subjects